Sign in

CIK 0001787306

  • Large accelerated filer

Arcutis Biotherapeutics, Inc.

Sign in to watch
Ticker
ARQT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812974255
Phone
+1 805-418-5006
Business address
3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
Former names
Arcutis, Inc.
  1. 4 Planned sale Director sold 10,000 shares at $18.92 ($189,227)
  2. 4 Planned sale Watanabe Todd sold 10,129 shares at an average $17.54 ($177,628)
  3. 4 Planned sale Matsuda Masaru sold 36,130 shares at $16.16 ($583,716)
  4. 4 Planned sale Director sold 10,000 shares at $15.64 ($156,383)
  5. 4 Planned sale Burnett Patrick sold 4,188 shares at an average $15.82 ($66,250)
  6. 4 Planned sale Burnett Patrick sold 3,847 shares at $14.03 ($53,988)
  7. 4 Planned sale Watanabe Todd sold 11,547 shares at $14.33 ($165,429)
  8. 4 Planned sale Burnett Patrick sold 2,622 shares at $14.33 ($37,564)
  9. 4 Planned sale SVP Chief Financial Officer sold 89 shares at $14.33 ($1,275)
  10. 4 Planned sale Matsuda Masaru sold 6,330 shares at $14.33 ($90,687)
  11. 4 Planned sale Director sold 10,000 shares at $14.30 ($142,982)
  12. 4 Planned sale Burnett Patrick sold 28,750 shares at an average $15.05 ($432,700)
  13. 4 Planned sale Director sold 9,208 shares at $13.84 ($127,430)
  14. 4 Planned sale Director sold 10,139 shares at $13.37 ($135,574)
  15. 4 Open-market buy Director bought 2,646 shares at $13.08 ($34,610)
  16. 4 Grant or award Director acquired 7,609 shares (grant or award)
  17. 4 Grant or award Director acquired 7,609 shares (grant or award)
  18. 4 Grant or award Director acquired 7,609 shares (grant or award)
  19. 4 Grant or award Director acquired 7,609 shares (grant or award)
  20. 4 Grant or award Director acquired 7,609 shares (grant or award)

Page 5 of 23 · 452 filings